Pregled bibliografske jedinice broj: 121818
HORMONE REPLACEMENT THERAPY - Is There a Place for its Use in Neurology?
HORMONE REPLACEMENT THERAPY - Is There a Place for its Use in Neurology? // Collegium antropologicum, 27 (2003), 1; 413-424 (recenziran, članak, stručni)
CROSBI ID: 121818 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
HORMONE REPLACEMENT THERAPY - Is There a Place for its Use in Neurology?
Autori
Vuković, Vlasta ; Lovrenčić Huzjan, Arijana ; Vargek Solter, Vesna ; Đorđević, Veljko ; Demarin, Vida
Izvornik
Collegium antropologicum (0350-6134) 27
(2003), 1;
413-424
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
hormone replacement therapy; stroke; postmenopause
Sažetak
Stroke remains the third leading cause of mortality in developed countries despite declining tendency over the past decades. As the leading cause of disability and second cause of dementia, primary prevention should be the main way to fight the disease, since therapy is not efficient enough. Several observations pointed to estrogen as a protective agent that may reduce stroke risk, however, studies have shown conflicting data. There is no strong evidence that hormone replacement therapy (HRT) increases stroke risk, but studies have shown that HRT may reduce the risk of fatal stroke. Conflicting results have been found for Alzheimer's disease and HRT as well. An association between higher serum concentrations of estradiol and decreased risk of cognitive decline has been found in some studies, supporting the hypothesis that estrogen concentrations may play a significant role in brain protection. Having in mind results of recent randomized trials, it is suggested that HRT should not be recommended on general basis for the primary or secondary prevention of cardiovascular/cerebrovascular diseases or for primary prevention of degenerative diseases such as Alzheimer's disease. Osteoporosis, cognitive decline and climacteric symptoms that are likely to impact on quality of life, speak in favour for recommendation of HRT use. On the other side, family history of breast carcinoma, mastopathy, thromboembolism, in certain cases gallbladder disease, will discourage the commencement of HRT. Respecting the patients preferences and having benefits and risks in mind as well as science advisory statements, individual counseling regarding HRT should be the leading concept in the healthcare of postmenopausal women.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0134015
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Veljko Đorđević
(autor)
Arijana Lovrenčić-Huzjan
(autor)
Vida Demarin
(autor)
Vesna Vargek-Solter
(autor)
Vlasta Vuković Cvetković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica